tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

CytoMed Therapeutics Ltd

GDTC
Add to Watchlist
0.910USD
0.0000.00%
Close 09-22 16:00（ET）
10.77MMarket Cap
LossP/E TTM

CytoMed Therapeutics Ltd

0.910
0.0000.00%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

GDTC Financials

See CytoMed Therapeutics Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
10.77M
Dividend TTM
0.00
P/E TTM
-5.70
EPS TTM
-0.16
Revenue
252.30K
Net Profit
-2.52M
ROE
-24.90%
ROA
-22.48%

CytoMed Therapeutics Ltd Earnings Date

Latest Release
Mar 31, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2025H2
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
Financial Indicators
EPS
----
---0.09
----
----
----
----
----
----
----
----
----
Revenue
146.76%131.08K
--53.12K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
-23.76%-1.35M
24.72%-1.09M
47.29%-847.13K
9.29%-1.45M
-116.45%-1.61M
-108.74%-1.60M
1.03%-742.59K
28.07%-765.78K
-97.51%-750.29K
---1.06M
---379.87K
Net Margin
----
---2062.30%
----
----
----
----
----
----
----
----
----
Gross Margin
----
--100.00%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
--4.60%
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
146.76%131.08K
--53.12K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
-152.22%-1.71M
52.62%-679.72K
18.58%-1.28M
-74.71%-1.43M
-176.63%-1.57M
-12.79%-821.18K
-2.31%-568.83K
-22.68%-728.05K
-57.41%-555.99K
---593.43K
---353.22K
Net Profit
-23.76%-1.35M
24.72%-1.09M
47.29%-847.13K
9.29%-1.45M
-116.45%-1.61M
-108.74%-1.60M
1.03%-742.59K
28.07%-765.78K
-97.51%-750.29K
---1.06M
---379.87K
Balance Sheet
Current assets
-37.87%2.85M
-38.14%4.59M
-29.77%6.00M
297.22%7.41M
420.54%8.54M
-23.77%1.87M
-53.61%1.64M
--2.45M
--3.54M
----
----
Total current liabilities
18.99%551.67K
-11.93%463.64K
18.79%278.58K
-83.11%526.43K
-89.78%234.51K
42.28%3.12M
12.02%2.29M
--2.19M
--2.05M
----
----
Total assets
-19.27%6.21M
-15.28%7.69M
-18.06%8.49M
132.17%9.08M
169.53%10.36M
-13.80%3.91M
-24.86%3.84M
--4.54M
--5.12M
----
----
Total liabilities
12.45%880.04K
-5.24%782.60K
4.89%582.83K
-76.22%825.84K
-79.28%555.65K
33.35%3.47M
8.50%2.68M
--2.60M
--2.47M
----
----
Total equity
-22.87%5.33M
-16.28%6.91M
-19.36%7.91M
1781.63%8.26M
743.19%9.81M
-77.31%438.78K
-56.03%1.16M
--1.93M
--2.65M
----
----
Cash Flow Statement
Net operating income
-37.19%-1.64M
-15.90%-1.20M
41.28%-907.29K
-41.14%-1.03M
-278.68%-1.54M
14.10%-730.99K
19.21%-408.00K
-158.71%-850.98K
-35.17%-505.02K
---328.93K
---373.61K
Net investment
-67.86%740.45K
211.58%2.30M
63.87%-1.47M
-5285.17%-2.06M
-1191.29%-4.07M
90.96%-38.34K
-68.67%-314.91K
-50.61%-424.19K
-84.43%-186.70K
---281.65K
---101.23K
Net financing
1141.14%197.68K
-575.33%-18.99K
-100.19%-15.36K
-99.53%3.99K
28621.89%8.16M
247.78%847.37K
-100.99%-28.62K
-67.84%243.65K
308.91%2.90M
--757.54K
--709.50K

FAQs

What is the total revenue of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its total revenue reached 252.30K, with a year-on-year change of 53.12K.

What are the current assets of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its current assets were 2.85M, with a year-on-year change of -37.88.

What are the total assets of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its total assets of CytoMed Therapeutics Ltd were 6.21M, with a year-on-year change of -19.29.

What are the total liabilities of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its total liabilities of CytoMed Therapeutics Ltd were 879.90K, with a year-on-year change of 12.43.

What is the total equity of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its total equity of CytoMed Therapeutics Ltd was 5.33M, with a year-on-year change of -22.88.

What is the net operating income of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its net operating income of CytoMed Therapeutics Ltd was -3.30M, with a year-on-year change of -70.25.

What is the net investment of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its net investment of CytoMed Therapeutics Ltd was 722.78K, with a year-on-year change of -16.05.

What is the net financing of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its net financing of CytoMed Therapeutics Ltd was 178.54K, with a year-on-year change of 624.03.

What is the Earnings Per Share (EPS) of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.27, with a year-on-year change of -66.42.

What is the net income of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its net income was -3.10M, with a year-on-year change of -60.95.

What is the net margin of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its net profit margin was -1231.97, with a year-on-year change of 66.05.

What is the gross margin of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its gross margin was 25.10, with a year-on-year change of -74.90.

What is the debt-to-asset ratio of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its debt-to-asset ratio was 6.04, with a year-on-year change of 31.34.

What is the Return on Equity (ROE) of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its Return on Equity (ROE) was -51.33, with a year-on-year change of -106.10.

What is the Return on Assets (ROA) of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its Return on Assets (ROA) was -44.27, with a year-on-year change of -96.95.

What is the operating profit of CytoMed Therapeutics Ltd?

According to CytoMed Therapeutics Ltd's FY2025 earnings report, its operating profit was -3.30M, with a year-on-year change of -70.25.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy